SCHEMBL3363100

SCHEMBL3363100

O=C1c2ccccc2C(=O)c2c(/N=N/c3ccccc3)c(S(=O)(=O)O)cc(NC3CCCCC3)c21

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 3/20 0.52
▸ HSD17B10 Q99714 3/20 0.52
▸ CYP1A2 P05177 2/20 0.52
▸ MAPK1 P28482 2/20 0.52
▸ CYP2C19 P33261 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ MAPT P10636 5/20 0.44
▸ TP53 P04637 3/20 0.44
▸ THRB P10828 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ POLB P06746 1/20 0.39
▸ GNG2 P59768 4/20 0.39
▸ GNB1 P62873 4/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ PGAM1 P18669 3/20 0.38
▸ CYP2C9 P11712 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ P2RY4 P51582 1/20 0.36
▸ PHLPP2 Q6ZVD8 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3363102 1.00 HIF1A (0.52) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3363868 0.93 CYP1A2 (0.59) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3363866 0.93 CYP1A2 (0.59) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL13496251 0.93 CYP1A2 (0.59) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3363622 0.92 HIF1A (0.47) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3363626 0.92 HIF1A (0.47) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3364255 0.91 MAPK1 (0.52) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3364259 0.91 MAPK1 (0.52) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL13496261 0.91 MAPK1 (0.52) HIF1AHSD17B10CYP1A2MAPK1CYP2C19
SCHEMBL3366816 0.86 HIF1A (0.50) HIF1AHSD17B10CYP1A2MAPK1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100031452-A1 AZO DYES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2010-02-11 — — US disclosed
US-20100031452-A1 AZO DYES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2010-02-11 — — US disclosed
US-20100031452-A1 AZO DYES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2010-02-11 — — US disclosed
WO-2010003969-A2 NEW AZO DYES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2010-01-14 — — WO disclosed
WO-2010003969-A2 NEW AZO DYES UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) 2010-01-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100031452-A1 AZO DYES IK, H1-10, RB1 HIF1A 3015/4885HSD17B10 1678/4885CYP1A2 217/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback